Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center [0.03%]
国王侯赛因癌症中心自体干细胞移植治疗霍奇金淋巴瘤20年疗效变化分析
Zaid Abdel Rahman,Abeer Yaseen,Anas Zayed et al.
Zaid Abdel Rahman et al.
Autologous hematopoietic stem cell transplantation (auto-HCT) remains a cornerstone in relapsed Hodgkin lymphoma (HL), especially where access to novel agents is limited. We evaluated trends in outcomes after auto-HCT at King Hussein Cancer...
Reduced dose versus standard melphalan conditioning for autologous stem cell transplantation in multiple myeloma: a single-center retrospective study [0.03%]
自体干细胞移植治疗多发性骨髓瘤低剂量化疗与标准剂量化疗的比较：一项单中心回顾性研究
Yifan Yao,Shan Zhang,Ziying Li et al.
Yifan Yao et al.
This retrospective, single‑center study evaluated the efficacy and safety of a reduced‑dose melphalan conditioning regimen (140–180 mg/m2) for autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM) ineligible ...
Correction to: Overcoming transfusion-refractory anemia: partial splenic embolization to facilitate orthopedic surgery in β-thalassemia [0.03%]
Correction to : 治疗输血抵抗性贫血：β-地中海贫血患者骨科手术期间行部分脾动脉栓塞术的安全性和有效性
Qing Qing Ye,Xian Gui Zhou,Guang Yang et al.
Qing Qing Ye et al.
Published Erratum
Annals of hematology. 2026 Mar 6;105(4):165. DOI:10.1007/s00277-026-06928-y 2026
Real-world single-center experience with pixantrone in DLBCL prior to its withdrawal: clinical outcomes and exploratory immunologic observations [0.03%]
pixantron在被撤市前用于治疗DLBCL的单中心真实世界体验：临床结果及探索性免疫学观察
Andrea Duminuco,Nunziatina Laura Parrinello,Laura Anastasia Caruso et al.
Andrea Duminuco et al.
Immune reconstruction after allogeneic hematopoietic stem cell transplantation: rules, mechanisms, and applications [0.03%]
allo-HSCT后免疫重建的规律、机制及应用
Chen-Mo Li,Qiu-Yi Wang,Zhi-Gang Chen et al.
Chen-Mo Li et al.
Immune reconstitution (IR) is a critical factor influencing the quality of life and long-term prognosis in hematopoietic stem cell transplant (HSCT) recipients. But delayed IR post-transplant may lead to infections and disease recurrence, w...
Hemopoietic stem cell transplantation for infectious mononucleosis-related aplastic anemia [0.03%]
与传染性单核细胞增多症相关再生障碍性贫血的造血干细胞移植
Stefano Cordella,Andrea Gilioli,Valeria Pioli et al.
Stefano Cordella et al.
We report the case of a young woman who developed aplastic anemia (AA), following a serologically confirmed primary Epstein–Barr virus (EBV) infection, occurring with fever and pharyngotonsillitis, in the absence of either palpable lymph n...
Comparison of the diagnostic performance of machine learning algorithms for differentiating iron deficiency anemia and thalassemia [0.03%]
机器学习算法在缺铁性贫血和地中海贫血鉴别诊断中的性能比较
Yun Wang,Xu Yuan,Weiwei Xiao et al.
Yun Wang et al.
Accurate discrimination between iron deficiency anemia (IDA) and thalassemia trait (TT) is clinically essential for the effective management of patients with hypochromic microcytic anemia. Although numerous discrimination indices based on r...
Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients [0.03%]
地中海贫血的治疗变革——回顾性研究造血干细胞移植在输血依赖型儿童患者中的应用价值
Lihua Huang,Zhenbin Wei,Gaohui Yang et al.
Lihua Huang et al.
Hematopoietic stem cell transplantation (HSCT) is the only definitive cure for transfusion-dependent α-thalassemia, though comprehensive studies on its effectiveness are limited. In this retrospective study, we analyzed the clinical charac...
From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN study [0.03%]
原发性血小板增多症转为真性红细胞增多症（ET-2-PV）：ELN多中心研究的合理性与设计
Tiziano Barbui,Jürgen Thiele,Alberto Alvarez-Larran et al.
Tiziano Barbui et al.
Essential thrombocythemia (ET) and polycythemia vera (PV) are traditionally viewed as distinct Philadelphia chromosome–negative myeloproliferative neoplasms, yet both frequently harbor the JAK2V617F mutation, suggesting a biological contin...
An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective study [0.03%]
一项基于多中心回顾性研究的晚期结外NK/T细胞淋巴瘤的炎症整合型预后预测模型
Yongle Xia,Yinjie Zhang,Renqin Li et al.
Yongle Xia et al.
Extranodal natural killer/T-cell lymphoma (ENKTL) is a rare and aggressive malignancy with poor outcomes in advanced stages. Current prognostic indices fail to fully account for the heterogeneity of stage Ⅲ–Ⅳ ENKTL. We aimed to develop a...